Isoeugenol is an important contact allergen: can it be safely replaced with isoeugenyl acetate?
The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97–54–1) is an important individual allergen. Until May 1998, the IFRA (International Fragrance Assocation) guidelines suggested that isoeugenol could safely be used at a l...
Saved in:
Published in | Contact dermatitis Vol. 41; no. 5; pp. 272 - 275 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.11.1999
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 0105-1873 1600-0536 |
DOI | 10.1111/j.1600-0536.1999.tb06160.x |
Cover
Abstract | The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97–54–1) is an important individual allergen. Until May 1998, the IFRA (International Fragrance Assocation) guidelines suggested that isoeugenol could safely be used at a level of 0.2% in consumer products. In May 1998, IFRA recommended that isoeugenol should not be used at a level that exceeds 0.02% in consumer products, but did not provide guidance on allergen substitution. An alternative to isoeugenol, based on aroma and absence of guide‐lines on use, is isoeugenyl acetate (CAS 93–29–8). 155 consecutive subjects were patch tested to isoeugenyl acetate (1.2%, 0.4%, 0.13% eth.) and isoeugenol 1% pet. 6 (3.9%) had an allergic reaction to 1.2% isoeugenyl acetate at D4. The reactions to the other 2 dilutions tended to be graded. 8 individuals had at least a palpable erythema by D4 to isoeugenol 1% pet. The majority of individuals allergic to isoeugenol were also intolerant of isoeugenyl acetate. Effective labelling of fragrance substances on consumer products will facilitate monitoring of exposure. |
---|---|
AbstractList | The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97–54–1) is an important individual allergen. Until May 1998, the IFRA (International Fragrance Assocation) guidelines suggested that isoeugenol could safely be used at a level of 0.2% in consumer products. In May 1998, IFRA recommended that isoeugenol should not be used at a level that exceeds 0.02% in consumer products, but did not provide guidance on allergen substitution. An alternative to isoeugenol, based on aroma and absence of guide‐lines on use, is isoeugenyl acetate (CAS 93–29–8). 155 consecutive subjects were patch tested to isoeugenyl acetate (1.2%, 0.4%, 0.13% eth.) and isoeugenol 1% pet. 6 (3.9%) had an allergic reaction to 1.2% isoeugenyl acetate at D4. The reactions to the other 2 dilutions tended to be graded. 8 individuals had at least a palpable erythema by D4 to isoeugenol 1% pet. The majority of individuals allergic to isoeugenol were also intolerant of isoeugenyl acetate. Effective labelling of fragrance substances on consumer products will facilitate monitoring of exposure. The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97-54-1) is an important individual allergen. Until May 1998, the IFRA (International Fragrance Association) guidelines suggested that isoeugenol could safely be used at a level of 0.2% in consumer products. In May 1998, IFRA recommended that isoeugenol should not be used at a level that exceeds 0.02% in consumer products, but did not provide guidance on allergen substitution. An alternative to isoeugenol, based on aroma and absence of guidelines on use, is isoeugenyl acetate (CAS 93-29-8). 155 consecutive subjects were patch tested to isoeugenyl acetate (1.2%, 0.4%, 0.13% eth.) and isoeugenol 1% pet. 6 (3.9%) had an allergic reaction to 1.2% isoeugenyl acetate at D4. The reactions to the other 2 dilutions tended to be graded. 8 individuals had at least a palpable erythema by D4 to isoeugenol 1% pet. The majority of individuals allergic to isoeugenol were also intolerant of isoeugenyl acetate. Effective labelling of fragrance substances on consumer products will facilitate monitoring of exposure.The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97-54-1) is an important individual allergen. Until May 1998, the IFRA (International Fragrance Association) guidelines suggested that isoeugenol could safely be used at a level of 0.2% in consumer products. In May 1998, IFRA recommended that isoeugenol should not be used at a level that exceeds 0.02% in consumer products, but did not provide guidance on allergen substitution. An alternative to isoeugenol, based on aroma and absence of guidelines on use, is isoeugenyl acetate (CAS 93-29-8). 155 consecutive subjects were patch tested to isoeugenyl acetate (1.2%, 0.4%, 0.13% eth.) and isoeugenol 1% pet. 6 (3.9%) had an allergic reaction to 1.2% isoeugenyl acetate at D4. The reactions to the other 2 dilutions tended to be graded. 8 individuals had at least a palpable erythema by D4 to isoeugenol 1% pet. The majority of individuals allergic to isoeugenol were also intolerant of isoeugenyl acetate. Effective labelling of fragrance substances on consumer products will facilitate monitoring of exposure. The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97-54-1) is an important individual allergen. Until May 1998, the IFRA (International Fragrance Association) guidelines suggested that isoeugenol could safely be used at a level of 0.2% in consumer products. In May 1998, IFRA recommended that isoeugenol should not be used at a level that exceeds 0.02% in consumer products, but did not provide guidance on allergen substitution. An alternative to isoeugenol, based on aroma and absence of guidelines on use, is isoeugenyl acetate (CAS 93-29-8). 155 consecutive subjects were patch tested to isoeugenyl acetate (1.2%, 0.4%, 0.13% eth.) and isoeugenol 1% pet. 6 (3.9%) had an allergic reaction to 1.2% isoeugenyl acetate at D4. The reactions to the other 2 dilutions tended to be graded. 8 individuals had at least a palpable erythema by D4 to isoeugenol 1% pet. The majority of individuals allergic to isoeugenol were also intolerant of isoeugenyl acetate. Effective labelling of fragrance substances on consumer products will facilitate monitoring of exposure. |
Author | Bruze, M. Arnau, E. Giménez Lepoittevin, J.-P. Menné, T. Goossens, A. Andersen, K. E. Johansen, J. D. Frosch, P. J. White, I. R. Rastogi, S. |
Author_xml | – sequence: 1 givenname: I. R. surname: White fullname: White, I. R. organization: St. Johns Institute of Dermatology, London, England – sequence: 2 givenname: J. D. surname: Johansen fullname: Johansen, J. D. organization: Department of Dermatology, Gentofte Hospital, University of Copenhagen, Denmark – sequence: 3 givenname: E. Giménez surname: Arnau fullname: Arnau, E. Giménez organization: Laboratorie de Dermatochimie, University Louis Pasteur, Strasbourg, France – sequence: 4 givenname: J.-P. surname: Lepoittevin fullname: Lepoittevin, J.-P. organization: Laboratorie de Dermatochimie, University Louis Pasteur, Strasbourg, France – sequence: 5 givenname: S. surname: Rastogi fullname: Rastogi, S. organization: National Environmental Research Institute, Roskilde, Denmark – sequence: 6 givenname: M. surname: Bruze fullname: Bruze, M. organization: Department of Occupational Dermatology, Malmo, Sweden – sequence: 7 givenname: K. E. surname: Andersen fullname: Andersen, K. E. organization: Department of Dermatology, Odense University, Denmark – sequence: 8 givenname: P. J. surname: Frosch fullname: Frosch, P. J. organization: Hautklinik, University of Witten/Herdecke, Dortmund, Germany – sequence: 9 givenname: A. surname: Goossens fullname: Goossens, A. organization: Department of Dermatology, Katholieke Universiteit Leuven, Belgium – sequence: 10 givenname: T. surname: Menné fullname: Menné, T. organization: Department of Dermatology, Gentofte Hospital, University of Copenhagen, Denmark |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1961849$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10554062$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkUFv1DAQhS1URLcLfwFZCHFLsOPEjnugoC20FYVeQEi9WI53DF68yWJ71d1_j6MsrcQJfLH05s2nmXkn6KgfekDoBSUlze_1qqSckII0jJdUSlmmjvAslbtHaHZfOkIzQklT0FawY3QS44oQyuuqfYKOs97UhFczpK7iANvv0A8eu4h1j916M4Sk-4TN0CdtEtbeQ8iWU2zGesId4Kgt-D0OsPHawBLfufQjAybW3uMsJp3g7Cl6bLWP8Ozwz9HXD--_LC6L65uLq8W768LUTFSFFa0glsiWWOiWkhm7ZA1oqTOnZrJtWy2hga6tDLVUGpFlWnEQgjBqOsPm6NXE3YTh1xZiUmsXDXivexi2UXFZ1fV4ijl6fjBuuzUs1Sa4tQ579eck2fDyYNDRaG-D7o2LDz7JaVvLbHs72UwYYgxglXF5Y5dvFrTzmafGsNRKjYmoMRE1hqUOYaldRpz-hXgY5h-a30zNd87D_j861eLmvBLjnsUEcDHB7h6gw0_FBRON-vb5QpHbW84vP31U5-w349W9tg |
CODEN | CODEDG |
CitedBy_id | crossref_primary_10_1016_j_hermed_2023_100778 crossref_primary_10_1016_j_jaci_2018_11_004 crossref_primary_10_1080_0972060X_2016_1238783 crossref_primary_10_1111_j_1600_0536_2007_01067_x crossref_primary_10_1111_j_1600_0536_2011_01877_x crossref_primary_10_3390_12081836 crossref_primary_10_1111_j_1600_0536_2011_02004_4_x crossref_primary_10_1111_j_0105_1873_2005_00576_x crossref_primary_10_1111_j_1600_0536_2007_01283_x crossref_primary_10_1111_j_1365_2133_2007_08017_x crossref_primary_10_3109_08923973_2011_591800 crossref_primary_10_1111_j_0105_1873_2004_00446_x crossref_primary_10_1016_j_foodchem_2022_133519 crossref_primary_10_1111_cod_12127 crossref_primary_10_1093_toxsci_60_1_112 crossref_primary_10_2903_j_efsa_2012_2532 crossref_primary_10_1046_j_1365_2133_2000_03406_x crossref_primary_10_2165_00128071_200304110_00006 |
Cites_doi | 10.1111/j.1600-0536.1995.tb02048.x 10.1016/S1046-199X(96)90078-0 10.1111/j.1600-0536.1997.tb00418.x 10.1046/j.1365-2133.1996.d01-1014.x 10.1007/978-3-642-74299-6_24 10.1111/j.1600-0536.1997.tb02435.x |
ContentType | Journal Article |
Copyright | 1999 INIST-CNRS |
Copyright_xml | – notice: 1999 INIST-CNRS |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/j.1600-0536.1999.tb06160.x |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0536 |
EndPage | 275 |
ExternalDocumentID | 10554062 1961849 10_1111_j_1600_0536_1999_tb06160_x COD272 ark_67375_WNG_0ZZ66HMK_D |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Europe |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 29F 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABHFT ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LMP LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHHS ACCFJ ADZOD AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE WRC WUP AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c4372-f7870f0980febd93cfd35ea9aace439888a9e5eb82c1f19c7ce4126e77031cbc3 |
IEDL.DBID | DR2 |
ISSN | 0105-1873 |
IngestDate | Thu Jul 10 20:03:09 EDT 2025 Wed Feb 19 02:32:38 EST 2025 Wed Apr 02 07:22:09 EDT 2025 Wed Oct 01 04:18:05 EDT 2025 Thu Apr 24 22:52:27 EDT 2025 Wed Jan 22 17:03:01 EST 2025 Sun Sep 21 06:18:49 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Cosmetic Human Immunopathology Allergy Skin disease Contact dermatitis Toxicity Perfume Harmlessness Substitute Recommendation Allergen |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4372-f7870f0980febd93cfd35ea9aace439888a9e5eb82c1f19c7ce4126e77031cbc3 |
Notes | ArticleID:COD272 ark:/67375/WNG-0ZZ66HMK-D istex:F4572F76F34018CC42BAE375540174F8273D6B90 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 10554062 |
PQID | 69244187 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_69244187 pubmed_primary_10554062 pascalfrancis_primary_1961849 crossref_citationtrail_10_1111_j_1600_0536_1999_tb06160_x crossref_primary_10_1111_j_1600_0536_1999_tb06160_x wiley_primary_10_1111_j_1600_0536_1999_tb06160_x_COD272 istex_primary_ark_67375_WNG_0ZZ66HMK_D |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | November 1999 |
PublicationDateYYYYMMDD | 1999-11-01 |
PublicationDate_xml | – month: 11 year: 1999 text: November 1999 |
PublicationDecade | 1990 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | Contact dermatitis |
PublicationTitleAlternate | Contact Dermatitis |
PublicationYear | 1999 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | Uter W, Schnuch A, Geier J, Frosch P. Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany. Eur J Dermatol 1998: 1: 36-40. Frosch P, Pilz B, Andersen K E et al. Results from a multi-center study of the european Environmental and Contact Dermatitis Research Group with 48 frequently used constituents of perfumes. Contact Dermatitis 1995: 33: 333-342. Johansen J D, Rastogi S C, Menné T. Contact allergy to popular perfumes; assessed by patch test, use test and chemical analysis. Br J Derm 1996: 135: 419-422. Larsen W, Nakayama H, Lindberg M, Fischer et al. Fragrance contact dermatitis: A worldwide multicentre investigation (Part 1). Am J Contact Dermatitis 1996: 7: 77-83. Buckley D A, Wakelin S H, Seed P T, Holloway D, Rycroft R J G, White I R, McFadden J P. The frequency of fragrance allergy in a patch test population over a seventeen-year period. Brit J Derm 1999: 40: (in press). Inventory of Cosmetic Ingredients. Official Journal of the European Communities, L132: vol. 39, 1 June 1996. Section II of the Annex to Commission Decision 96/335/EC in accordance with Council Directive 93/35/EEC (art 5a.1) (http://www.dg3.eudra.org/Inci/Frag_mn.htm). De Groot A C, Frosch P J. Adverse reactions to fragrances. A clinical review. Contact Dermatitis 1997: 36: 57-87. Schnuch A, Geier J, Uter W, Frosch P J et al. National rates and regional differences in sensitization to allergens of the standard series. Population adjusted frequencies of sensitization (PAFS) in 40 000 patients from a multicenter study (IVDK). Contact Dermatitis 1997: 37: 200-209. 1998 1 June 1996; 39 1998; 1 1999; 40 1996; 135 1997; 37 1997; 36 1989 1995; 33 1996; 7 e_1_2_1_6_2 Uter W (e_1_2_1_7_2) 1998; 1 e_1_2_1_4_2 e_1_2_1_5_2 e_1_2_1_3_2 Buckley D A (e_1_2_1_9_2) 1999; 40 e_1_2_1_10_2 Johansen J D (e_1_2_1_2_2) 1996; 135 Inventory of Cosmetic Ingredients (e_1_2_1_11_2) 1996; 39 e_1_2_1_8_2 10750869 - Contact Dermatitis. 2000 Apr;42(4):249 |
References_xml | – reference: Frosch P, Pilz B, Andersen K E et al. Results from a multi-center study of the european Environmental and Contact Dermatitis Research Group with 48 frequently used constituents of perfumes. Contact Dermatitis 1995: 33: 333-342. – reference: Larsen W, Nakayama H, Lindberg M, Fischer et al. Fragrance contact dermatitis: A worldwide multicentre investigation (Part 1). Am J Contact Dermatitis 1996: 7: 77-83. – reference: Schnuch A, Geier J, Uter W, Frosch P J et al. National rates and regional differences in sensitization to allergens of the standard series. Population adjusted frequencies of sensitization (PAFS) in 40 000 patients from a multicenter study (IVDK). Contact Dermatitis 1997: 37: 200-209. – reference: Johansen J D, Rastogi S C, Menné T. Contact allergy to popular perfumes; assessed by patch test, use test and chemical analysis. Br J Derm 1996: 135: 419-422. – reference: Inventory of Cosmetic Ingredients. Official Journal of the European Communities, L132: vol. 39, 1 June 1996. Section II of the Annex to Commission Decision 96/335/EC in accordance with Council Directive 93/35/EEC (art 5a.1) (http://www.dg3.eudra.org/Inci/Frag_mn.htm). – reference: Uter W, Schnuch A, Geier J, Frosch P. Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany. Eur J Dermatol 1998: 1: 36-40. – reference: De Groot A C, Frosch P J. Adverse reactions to fragrances. A clinical review. Contact Dermatitis 1997: 36: 57-87. – reference: Buckley D A, Wakelin S H, Seed P T, Holloway D, Rycroft R J G, White I R, McFadden J P. The frequency of fragrance allergy in a patch test population over a seventeen-year period. Brit J Derm 1999: 40: (in press). – volume: 37 start-page: 200 year: 1997 end-page: 209 article-title: National rates and regional differences in sensitization to allergens of the standard series. Population adjusted frequencies of sensitization (PAFS) in 40 000 patients from a multicenter study (IVDK) publication-title: Contact Dermatitis – start-page: 127 year: 1989 end-page: 131 – volume: 135 start-page: 419 year: 1996 end-page: 422 article-title: Contact allergy to popular perfumes; assessed by patch test, use test and chemical analysis publication-title: Br J Derm – volume: 40 year: 1999 article-title: The frequency of fragrance allergy in a patch test population over a seventeen‐year period publication-title: Brit J Derm – volume: 1 start-page: 36 year: 1998 end-page: 40 article-title: Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany publication-title: Eur J Dermatol – volume: 36 start-page: 57 year: 1997 end-page: 87 article-title: Adverse reactions to fragrances. A clinical review publication-title: Contact Dermatitis – volume: 33 start-page: 333 year: 1995 end-page: 342 article-title: Results from a multi‐center study of the european Environmental and Contact Dermatitis Research Group with 48 frequently used constituents of perfumes publication-title: Contact Dermatitis – volume: 39 start-page: L132 year: 1 June 1996 publication-title: Official Journal of the European Communities – year: 1998 – volume: 7 start-page: 77 year: 1996 end-page: 83 article-title: Fragrance contact dermatitis: A worldwide multicentre investigation (Part 1) publication-title: Am J Contact Dermatitis – volume: 40 year: 1999 ident: e_1_2_1_9_2 article-title: The frequency of fragrance allergy in a patch test population over a seventeen‐year period publication-title: Brit J Derm – ident: e_1_2_1_5_2 doi: 10.1111/j.1600-0536.1995.tb02048.x – ident: e_1_2_1_3_2 doi: 10.1016/S1046-199X(96)90078-0 – volume: 39 start-page: L132 year: 1996 ident: e_1_2_1_11_2 publication-title: Official Journal of the European Communities – volume: 1 start-page: 36 year: 1998 ident: e_1_2_1_7_2 article-title: Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany publication-title: Eur J Dermatol – ident: e_1_2_1_8_2 doi: 10.1111/j.1600-0536.1997.tb00418.x – ident: e_1_2_1_10_2 – volume: 135 start-page: 419 year: 1996 ident: e_1_2_1_2_2 article-title: Contact allergy to popular perfumes; assessed by patch test, use test and chemical analysis publication-title: Br J Derm doi: 10.1046/j.1365-2133.1996.d01-1014.x – ident: e_1_2_1_4_2 doi: 10.1007/978-3-642-74299-6_24 – ident: e_1_2_1_6_2 doi: 10.1111/j.1600-0536.1997.tb02435.x – reference: 10750869 - Contact Dermatitis. 2000 Apr;42(4):249 |
SSID | ssj0016428 |
Score | 1.6505191 |
Snippet | The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97–54–1) is an important... The prevalence of contact allergy to the fragrance mix in individuals with eczema is up to 10%. Within the mix, isoeugenol (CAS 97-54-1) is an important... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 272 |
SubjectTerms | allergen substitution Allergens Allergic diseases Biological and medical sciences Dermatitis, Allergic Contact - diagnosis Dermatitis, Allergic Contact - etiology Domestic and cosmetic products toxicology Eugenol - adverse effects Eugenol - analogs & derivatives fragrance allergy Humans Immunopathology isoeugenol isoeugenyl acetate Medical sciences Patch Tests Perfume - adverse effects Perfume - chemistry product labelling Skin allergic diseases. Stinging insect allergies Toxicology |
Title | Isoeugenol is an important contact allergen: can it be safely replaced with isoeugenyl acetate? |
URI | https://api.istex.fr/ark:/67375/WNG-0ZZ66HMK-D/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0536.1999.tb06160.x https://www.ncbi.nlm.nih.gov/pubmed/10554062 https://www.proquest.com/docview/69244187 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCO - Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1600-0536 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0016428 issn: 0105-1873 databaseCode: ABDBF dateStart: 19980101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0105-1873 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1600-0536 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016428 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB1VRaq48FU-AhR8QNxSxUlsx1yqqqVsQdtKiIqqF8t2bKnqNos2Wanl1-NxsksXgQSo10TjJJM3ybM98wbgDa29ozUzqdNSp2Xuy1QXxqQ618IwkRkTu5aMj_jopPx4yk6H8mishen1IZYLbhgZ8XuNAa5NuxrkHKuiWcGx5E7iGifHtRJklLRgcc_281JLiiLRjvmMKL1ZiWJQIB3Sev4w1Mrf6g46_gqzJ3UbHOj7zhe_o6arTDf-qg7uw-XiIfsMlYvteWe27fdf9B9vywsP4N7AacluD8KHsOaaR7AxHnbtN0EdtlM3RzXYCTlviW7I-WWk_U1HMFVe245gSxesA31HLJ7viHGk1d5NrsnMxcSxmuCacRigH-t6QsJBpMo7j-Hk4P2XvVE6NHZILW4Tph6_Ej6TVeadqWVhfV0wBEuwCwQpTMq1dMyZKrfUU2lFOExz7gSK7Vtjiyew3kwb9wxILnzAlqxqpmkZXFKxwDkslc5LV1pnE5CLF6jsoHqOzTcm6sbsJ3hQoQcVelANHlRXCRRL22-99sdfWb2NOFma6NkFZs8Jpr4efVDZ2Rnno_EntZ_A1gqQfl4jduGRCbxeAEuFmMeNHN246bxVPEyay4DhBJ72eLtxe4EeZjxPQETU_MN9q73j_Vzkz__b8gXcjZoWsVDzJax3s7nbCoytM69iJP4A204yiA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED9NmwS88P0RYMwPiLdM-bId84LQyujYUiS0iWkvlu3Y0rSSoiaVNv56fE5aVgQSIF5TnZtef5f8fL77HcDLtHY2ramOrRIqLjJXxCrXOlaZ4pryROswtaSasPFJ8eGUnm5AteyF6fUhVgk3jIzwvMYAx4T0epQzbIumOcOeO4FJTobJEk8pt_DADuN09GmlJpUi1Q4VjSi-WfJ80CAdCnt-s9ba-2oLXX-J9ZOq9S50_eyLX5HTda4bXlb7d6BZ_sy-RuVid9HpXfPtJwXI_-aHu3B7oLXkbY_De7Bhm_twoxoO7h-APGhndoGCsFNy3hLVkPMvgfk3HcFqeWU6glNdsBX0NTH4eUe0Ja1ydnpF5jbUjtUE08Z-gX6tqynxF5Etv3kIJ_vvjvfG8TDbITZ4Uhg7fFC4RJSJs7oWuXF1ThEv3s5zJL8vV8JSq8vMpC4VhvvLacYsR719o03-CDabWWOfAMm48_ASZU1VWniXlNTTDpMK64QtjDURiOU_KM0gfI7zN6by2gbIe1CiByV6UA4elJcR5Cvbr738xx9ZvQpAWZmo-QUW0HEqP0_ey-TsjLFxdShHEWyvIenHd4RBPCKCnSWypA97PMtRjZ0tWsn8vrnwII7gcQ-4a7fnGWLCsgh4gM1f3Lfc-zjKePb0ny134Ob4uDqSRweTw2dwK0hchL7N57DZzRd22xO4Tr8IYfkd_bQ2pA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB2hVqq4QPkOpdQHxC1VvmzHXBDqsmwpuyBERdWLZTu2VHWbrTZZqeXX43GySxeBBIhronGSyZvk2Z55A_AirZxNK6pjq4SKi8wVscq1jlWmuKY80Tp0LRlP2Oi4eH9CT_ryaKyF6fQhVgtuGBnhe40Bflm59SBnWBVNc4YldwLXOBmulXhGuVkwP91CivR5JSaVItMOCY2ovVnyvJcg7fN6fjPW2u9qEz1_hemTqvEedF3ri19x03WqG_5Vw7twsXzKLkXlfH_R6n3z7ScByP_lhm2405Na8qZD4T24Zev7sDXut-0fgDxsZnaBcrBTctYQVZOzi8D765ZgrrwyLcGeLlgI-ooYPN8SbUmjnJ1ek7kNmWMVwUVjP0A31vWU-IPIlV8_hOPh2y8Ho7jv7BAb3CeMHX4mXCLKxFldidy4KqeIFm_nGZKflSthqdVlZlKXCsP94TRjlqPavtEmfwQb9ay2T4Bk3HlwibKiKi28S0rqSYdJhXXCFsaaCMTyBUrTy55j942pvDH98R6U6EGJHpS9B-VVBPnK9rIT__gjq5cBJysTNT_H9DlO5dfJO5mcnjI2Gh_JQQS7a0D6cY3QhkdEsLcElvRBjzs5qrazRSOZnzUXHsMRPO7wduP2PD9MWBYBD6j5i_uWBx8HGc-e_rPlHmx9Ggzlh8PJ0Q7cDvoWoWjzGWy084Xd9eyt1c9DUH4HH0A1Uw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Isoeugenol+is+an+important+contact+allergen%3A+can+it+be+safely+replaced+with+isoeugenyl+acetate%3F&rft.jtitle=Contact+dermatitis&rft.au=White%2C+I+R&rft.au=Johansen%2C+J+D&rft.au=Arnau%2C+E+G&rft.au=Lepoittevin%2C+J+P&rft.date=1999-11-01&rft.issn=0105-1873&rft.volume=41&rft.issue=5&rft.spage=272&rft_id=info:doi/10.1111%2Fj.1600-0536.1999.tb06160.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-1873&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-1873&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-1873&client=summon |